Loading…
Dongxiao Biotechnology reported first-half 2026 revenue down 2.03% and net profit down 51.76%. The company blamed lower lysine prices, export restrictions and weak pig-sector demand.
Gross margin fell to 9.65%, and anti-dumping duties in the EU, US and Brazil were cited as pressure.
Weak Chinese lysine pricing and producer margin pressure point to continued cheap supply, though trade barriers limit export volumes. Feed buyers outside China may see stable to lower lysine costs.
agrospectrumasia.comAug 31, 2026Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
